Loading...
Loading...
India's ofloxacin imports from AUSTRALIA total $135 across 13 shipments from 1 foreign suppliers. ACRUX DDS PTY LTD leads with $135 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include RECIPHARM PHARMASERVICES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for ofloxacin โ a concentrated sourcing relationship with select suppliers from AUSTRALIA.

ACRUX DDS PTY LTD is the leading Ofloxacin supplier from AUSTRALIA to India, with import value of $135 across 13 shipments. The top 5 suppliers โ ACRUX DDS PTY LTD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACRUX DDS PTY LTD | $135 | 13 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RECIPHARM PHARMASERVICES PRIVATE LIMITED | $135 | 13 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ofloxacin suppliers from AUSTRALIA to India include ACRUX DDS PTY LTD. The leading supplier is ACRUX DDS PTY LTD with import value of $135 USD across 13 shipments. India imported Ofloxacin worth $135 USD from AUSTRALIA in total across 13 shipments.
India imported Ofloxacin worth $135 USD from AUSTRALIA across 13 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ofloxacin sourced from AUSTRALIA include RECIPHARM PHARMASERVICES PRIVATE LIMITED. The largest buyer is RECIPHARM PHARMASERVICES PRIVATE LIMITED with $135 in imports across 13 shipments.
The total value of Ofloxacin imports from AUSTRALIA to India is $135 USD, across 13 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists